Publication | Closed Access

Recurrent ovarian carcinoma: Retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agent

Combination ChemotherapyMedicineMetronomic TherapyRecurrent Ovarian CarcinomaGynecologyCancer TreatmentOncologyRadiation OncologyGynecology OncologyMolecular OncologyOvarian Cancer